Clinical trial

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

NCT06256991

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-04-01

PhasePHASE4

Study timeline

Study start (actual)2024-04-01Date precision: day

Registry last updated2025-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Kidney Diseasesunresolved

Hyperkalemiaunresolved

Hypertensionunresolved

Interventions

Patiromer 8400 MG [Veltassa]DRUG · verified · RxNorm: patiromer 8400 MG [Veltassa]

Sponsors & collaborators

University Medical Center Groningenlead sponsor

Amsterdam University Medical Centercollaborator

Frisius Medisch Centrumcollaborator

Isalacollaborator

Vifor Pharma, Inc.collaborator

Dutch Kidney Foundationcollaborator

Health Hollandcollaborator

Mapped research locations

GroningenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06256991 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.